Treatment of Atrial Septal Defect in Pregnancy
Most pregnant women with isolated ASD tolerate pregnancy well with conservative medical management alone, and intervention during pregnancy is rarely indicated. 1
Risk Stratification and Initial Management
Pregnant women with ASD should be evaluated in a specialized Cardiology of Pregnancy (COP) clinic as early as possible for risk stratification and delivery planning 1. The key determinants of maternal and fetal risk include:
- Shunt magnitude (Qp:Qs ratio)
- Right heart chamber enlargement
- Pulmonary artery pressures
- Presence of symptoms (NYHA functional class)
- Maternal oxygen saturation at rest and with exercise
Conservative Management (First-Line Approach)
For most pregnant women with ASD, medical management is the appropriate treatment strategy throughout pregnancy. This includes:
- Beta-blockers (e.g., bisoprolol) for rate control if arrhythmias develop
- Diuretics (e.g., furosemide) for volume management if symptomatic
- Activity modification based on symptoms
- Serial echocardiographic monitoring to assess right heart function and pulmonary pressures
- Pulse oximetry at rest and with exercise to detect shunt reversal 2
The physiologic changes of pregnancy—including 40% increase in cardiac output and decreased systemic vascular resistance—are generally well-tolerated in pretricuspid shunts like ASD 3. The left-to-right shunt typically does not worsen significantly because both cardiac output and pulmonary blood flow increase proportionally.
Indications for Intervention During Pregnancy
Intervention during pregnancy should only be considered in the rare circumstance of severe, refractory symptoms despite optimal medical therapy. 4, 5
When to Consider Percutaneous or Surgical Closure:
Intervention may be warranted if:
- Progressive NYHA class III-IV symptoms despite maximal medical therapy
- Significant right heart failure with hemodynamic compromise
- Severe pulmonary hypertension with evidence of maternal decompensation
Choice of Intervention:
If intervention is unavoidable, percutaneous device closure under transesophageal echocardiography (TEE) guidance without fluoroscopy is the preferred approach to avoid fetal radiation exposure 4, 5. This requires:
- Secundum ASD with adequate septal rims for device placement
- Experienced interventional team in a specialized center
- TEE guidance throughout the procedure to eliminate radiation
- Balloon-assisted technique may be needed for large defects (>30mm) 4
Surgical closure is reserved for:
- Anatomically unsuitable defects for percutaneous closure (inadequate rims, very large defects >35mm)
- Severe pulmonary hypertension requiring urgent intervention 6
- Associated anomalies requiring surgical correction
Critical Contraindications
ASD closure must NOT be performed if:
- Pulmonary artery systolic pressure >2/3 systemic pressure
- Pulmonary vascular resistance >2/3 systemic resistance
- Net right-to-left shunt present 2
These findings indicate Eisenmenger physiology, where closure would be harmful and potentially fatal.
Timing Considerations
Ideally, hemodynamically significant ASDs should be closed before pregnancy 7. Women with known ASD planning pregnancy should receive preconception counseling in a COP clinic, with consideration for elective closure if:
- Qp:Qs ≥1.5:1 with right heart enlargement
- History of paradoxical embolism
- Symptomatic with exercise limitation
Studies show that surgical correction before pregnancy reduces miscarriage rates, preterm delivery, and maternal cardiac symptoms compared to pregnancy with uncorrected defects 7.
Delivery Planning
Vaginal delivery is preferred for most women with ASD unless obstetric indications necessitate cesarean section 1. The delivery plan should specify:
- Hemodynamic monitoring during labor
- Endocarditis prophylaxis is NOT routinely indicated for isolated ASD
- Avoid excessive fluid administration to prevent volume overload
- Second stage shortening with assisted delivery if symptomatic
- Postpartum monitoring for 24-48 hours (highest risk period for decompensation)
Common Pitfalls to Avoid
- Do not assume all ASDs require closure during pregnancy—the vast majority are managed conservatively
- Do not perform closure in patients with elevated pulmonary vascular resistance without careful hemodynamic assessment
- Do not delay referral to specialized COP clinic if symptoms develop—early multidisciplinary involvement is critical 1
- Do not use fluoroscopy if intervention is needed—TEE-guided approaches eliminate fetal radiation exposure 4
Postpartum Management
Women remain at risk for cardiac decompensation in the immediate postpartum period due to autotransfusion from uterine involution. Continue cardiac monitoring for 24-48 hours postdelivery. Long-term cardiology follow-up should be arranged, with consideration for elective ASD closure after pregnancy if hemodynamically significant 1.